Skip to main content
OpenTrials

Clinical trial condition

Poxviridae Infections

Explore clinical trials studying Poxviridae Infections. Study availability and eligibility vary by location and protocol.

166 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Poxviridae Infections trial results

Completed

Study to Assess Brincidofovir Treatment of Serious Diseases or Conditions Caused by Double-stranded DNA Viruses

NCT01143181

Conditions
Adenoviridae Infections, DNA Virus Infections, Double-stranded DNA Virus, +11 more
Locations
  • Loma Linda University Hospital Loma Linda, California, United States
  • Children's Hospital of LA Los Angeles, California, United States
  • UCLA Department of Medicine Los Angeles, California, United States
  • CHOC Children's Orange, California, United States
View all 37 locations
View Trial Details
Completed

Freeze-Dried MVA-BN® Lot Consistency Smallpox Trial

NCT03699124

Conditions
DNA Virus Infections, Infections, Poxviridae Infections, +2 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Optimal Research, LLC (Synexus) Melbourne, Florida, United States
  • Optimal Research, LLC (Synexus) Peoria, Illinois, United States
  • University of Iowa Iowa City, Iowa, United States
View Trial Details
Completed

Lyophilized IMVAMUNE® (1x10^8 TCID50) Versus Liquid IMVAMUNE® (1x10^8 TCID50) Administered Subcutaneously and a Lower Dose Liquid IMVAMUNE® (2x10^7 TCID50) Administered Intradermally

NCT00914732

Conditions
DNA Virus Infections, Infections, Poxviridae Infections, +2 more
Locations
  • Emory Vaccine Center - The Hope Clinic Decatur, Georgia, United States
  • University of Iowa - Vaccine Research & Education Unit Iowa City, Iowa, United States
  • University of Maryland School of Medicine - Center for Vaccine Development - Baltimore Baltimore, Maryland, United States
  • Saint Louis University - Center for Vaccine Development St Louis, Missouri, United States
View Trial Details
Completed

Randomized, Open-label Phase II Trial to Assess the Safety and Immunogenicity of MVA-BN Smallpox Vaccine in Immunocompromised Subjects With HIV Infection

NCT02038881

Conditions
DNA Virus Infections, Infections, Poxviridae Infections, +2 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Health for Life Clinic Little Rock Little Rock, Arkansas, United States
  • Quest Clinical Research San Francisco, California, United States
  • Dupont Circle Physicians Group Washington D.C., District of Columbia, United States
View Trial Details
Completed

Cohort Study of Healthcare Workers Receiving Imvanex®

NCT03745131

Conditions
Animal Diseases, DNA Virus Infections, Infections, +6 more
Locations
  • Blackpool Teaching Hospitals NHS Foundation Trust Blackpool, Lancashire, United Kingdom
  • Royal Liverpool and Broadgreen University Hospitals NHS Trust Liverpool, Merseyside, United Kingdom
  • Newcastle Hospitals NHS Foundation Trust Newcastle upon Tyne, Tyne and Wear, United Kingdom
  • Royal Free London NHS Foundation Trust London, United Kingdom
View Trial Details

Related conditions